منابع مشابه
American Academy of Pediatrics and American Academy of Family Physicians
This evidence-based clinical practice guideline provides recommendations to primary care clinicians for the management of children from 2 months through 12 years of age with uncomplicated acute otitis media (AOM). The American Academy of Pediatrics and American Academy of Family Physicians convened a committee composed of primary care physicians and experts in the fields of otolaryngology, epid...
متن کاملAmerican Academy of Pediatrics and American Academy of Family Physicians
This evidence-based clinical practice guideline provides recommendations to primary care clinicians for the management of children from 2 months through 12 years of age with uncomplicated acute otitis media (AOM). The American Academy of Pediatrics and American Academy of Family Physicians convened a committee composed of primary care physicians and experts in the fields of otolaryngology, epid...
متن کاملAmerican Academy of Pediatrics and American Academy of Family Physicians
This evidence-based clinical practice guideline provides recommendations to primary care clinicians for the management of children from 2 months through 12 years of age with uncomplicated acute otitis media (AOM). The American Academy of Pediatrics and American Academy of Family Physicians convened a committee composed of primary care physicians and experts in the fields of otolaryngology, epid...
متن کاملAmerican Academy of Pediatrics and American Academy of Family Physicians
This evidence-based clinical practice guideline provides recommendations to primary care clinicians for the management of children from 2 months through 12 years of age with uncomplicated acute otitis media (AOM). The American Academy of Pediatrics and American Academy of Family Physicians convened a committee composed of primary care physicians and experts in the fields of otolaryngology, epid...
متن کاملAmerican academy of dermatology, summer academy meeting.
inhibit progression of joint destruction. He said that TNF inhibitors are unique in their ability to do that but added that uste kinumab is unproven in PsA. Although one pilot study indicated a degree of response,1 “the jury is still out,” he claimed. In his own experience, he said that ustekinumab did not perform as well as the TNF blockers—or methotrexate— against PsA. Regarding cardiovascula...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Operative Dentistry
سال: 2007
ISSN: 1559-2863,0361-7734
DOI: 10.2341/i1559-2863-32-1-99.1